investig
product
potenti
use
bovin
interferon
viral
infect
occur
sinc
first
descript
interferon
system
recent
advent
recombin
dnatechnolog
facilit
studi
further
knowledg
bovin
interferon
system
gener
review
give
overview
biolog
antivir
immunomodulatori
activ
bovin
interferon
area
interferon
appli
potenti
applic
viral
diseas
cattl
describ
final
valu
studi
bovin
interferon
system
respect
compar
interferon
research
discuss
isaac
lindemann
discov
reason
phenomenon
viral
interfer
anim
describ
number
investig
earli
factor
protein
produc
respons
viral
infect
subsequ
inhibit
infect
second
relat
unrel
viru
nonspecif
manner
discoveri
creat
great
excit
due
implic
antivir
agent
wide
spectrum
antivir
activ
use
viral
therapi
past
year
mani
aspect
interferon
ifn
system
elucid
includ
find
ifn
one
protein
famili
protein
multitud
biolog
physiolog
function
thu
ifn
power
antivir
agent
also
anticellular
activ
cancer
cell
well
plethora
effect
immun
system
recent
sever
comprehens
review
monograph
book
seri
multifari
aspect
ifn
biolog
includ
chemistri
gener
vivo
vitro
biolog
effect
henc
review
restrict
specif
bovin
ifn
system
brief
refer
gener
aspect
anim
speci
appropri
reader
therefor
refer
literatur
cite
gener
inform
data
specif
anim
speci
bovin
interferon
bolfn
probabl
constitut
anim
ifn
group
apart
human
murin
counterpart
known
present
time
regard
gene
code
protein
clinic
immunolog
effect
summar
tabl
addit
consider
given
sever
import
viral
infect
cattl
could
treat
ifn
well
use
model
human
diseas
herp
viru
infect
leukosi
neonat
virusdiarrhea
review
see
everi
good
reason
encourag
research
variou
aspect
bovin
ifn
system
attempt
give
brief
account
present
state
knowledg
relat
bovin
ifn
applic
bovin
medicin
gene
code
bolfnol
group
two
homolog
distinct
class
class
bolfnoq
respect
bolfnet
gene
famili
contain
approxim
member
sequepc
analys
homolog
within
famili
gene
famili
exhibit
greater
homolog
code
flank
region
member
class
human
interferona
hulfnat
gene
famili
bolfna
e
gene
famili
similarli
bolfnot
subfamili
contain
member
display
greater
homolog
member
class
hulfnot
gene
bolfncxf
gene
similar
human
bovin
ifna
gene
demonstr
fact
class
gene
code
matur
protein
amino
acid
wherea
class
gene
code
protein
amino
acid
length
speci
class
ifnot
gene
coordin
induc
respons
viral
infect
encod
polypeptid
antivir
activ
howev
whether
differ
ifna
gene
actual
express
ie
translat
given
encount
viru
cell
yet
elucid
indic
depend
viru
well
cell
type
bolfna
gene
may
differenti
express
czarniecki
et
al
unpublish
data
result
agreement
find
human
macrophag
produc
ifn
appear
ifn
induc
differ
virus
differ
antivir
activ
ie
antivir
spectrum
potenc
could
reflect
abil
differ
virus
depress
regul
differ
ifngen
infect
elucid
aspect
await
clone
product
ifnot
subtyp
either
class
gene
probe
avail
possibl
quantit
product
individu
ifnmrna
follow
infect
differ
virus
furthermor
avail
purifi
individu
ifn
subtyp
also
allow
investig
whether
specif
subtyp
differ
mechan
action
geneproduct
bolfnoq
gene
appear
possess
glycosyl
site
least
ifnprotein
encod
class
gene
appear
acid
labil
ph
shepard
et
al
unpublish
data
contrast
class
gene
product
fit
origin
physicochem
character
type
ifn
acid
labil
shepard
et
al
unpublish
data
find
may
explain
report
occurr
partial
acid
labil
natur
boifn
type
induc
primari
infect
cattl
cell
cultur
nonimmun
anim
ie
condit
ifn
product
could
exclud
gene
famili
appear
compris
least
homolog
yet
distinct
member
contrast
singl
gene
far
detect
human
genom
dna
sequenc
analysi
demonstr
exhibit
homolog
huifn
less
overal
homolog
correspond
genesequ
speci
point
recent
event
geneevolut
limit
studi
conduct
physicochem
properti
natur
boifn
recombin
produc
preliminari
data
appear
suggest
less
stabl
follow
purif
boifnc
unpublish
data
speci
one
gene
encod
ifnha
detect
bovin
boifnet
gene
share
similar
properti
ifn
gene
speci
contain
intron
contrast
ifna
gene
gene
product
boifn
bind
cell
receptor
distinguish
bielefeldt
ohmann
babiuk
unpublish
data
nevertheless
ifntyp
exhibit
least
activ
although
potenc
specif
activ
specif
biolog
reaction
vari
date
bolfn
gene
gene
bolfn
gene
clone
express
e
coli
recombin
dnatechnolog
avail
clone
product
greatli
increas
abil
conduct
thorough
analysi
antivir
immunomodulatori
effect
bovin
ifn
furthermor
allow
clinic
trial
conduct
product
potenti
use
prophylact
therapeut
compound
assess
first
report
ifnproduct
bovin
cell
publish
induct
achiev
infect
calf
kidney
cell
vitro
human
influenza
viru
sinc
multitud
primari
cell
cultur
system
establish
cell
line
organ
cultur
bovin
origin
virus
homolog
well
heterolog
employ
vitro
gener
ifn
see
refer
prior
cell
produc
variou
ifn
bovin
well
character
man
mice
review
see
howev
even
latter
speci
origin
clear
distinct
fibroblast
leukocyteifn
ie
aifn
respect
becom
blur
time
pass
cell
type
studi
distinct
ifntyp
also
becom
question
sinc
discoveri
sever
subspeci
ifn
within
ifngroup
may
show
overlap
physicochem
characterist
acidl
howev
use
monoclon
antibodi
hybrid
techniqu
possibl
improv
detect
identif
cell
produc
class
ifn
well
identifyclassifi
protein
produc
differ
condit
shepard
et
al
unpublish
data
mani
studi
bovin
ifn
produc
likelihood
consid
cell
type
use
report
acidst
well
defin
characterist
howev
case
especi
organ
cultur
employ
ifn
may
mixtur
ifna
due
presenc
contamin
macrophag
mqb
bovin
md
avid
ifnproduc
respons
vitro
viruschalleng
well
acellular
cellular
induc
ifn
produc
bovin
md
acid
labil
otherwis
physicochem
antigen
characterist
ifna
recent
found
belong
class
ifna
famili
previous
mention
characterist
acid
labil
shepard
et
al
unpublish
data
peripher
blood
leukocyt
pbl
seroneg
respect
calv
expos
infect
fibroblast
found
produc
ifna
shepard
et
al
unpublish
data
may
larg
produc
mb
popul
monocyt
present
pbl
contrast
fulton
rosenquist
detect
ifnact
pblcultur
nonimmun
calv
follow
infect
vitro
whether
discrep
due
challeng
dose
way
viru
introduc
vitro
system
ie
virusinfect
cell
cellfre
viru
suspens
sensit
ifnassay
present
known
latter
find
howev
surpris
sinc
infect
mb
viru
shown
rapidli
induc
high
level
ifn
pbl
cultur
immun
anim
major
type
ifn
produc
upon
vitro
reexposur
antigen
whether
viru
virusinfect
cell
antigen
ifn
speci
produc
cell
resid
cell
popul
product
ifn
popul
least
partial
depend
presenc
mqb
accessori
cell
bovin
leukocyt
ms
lymphocyt
may
also
produc
ifn
ifnlik
substanc
respons
viru
exposur
rous
et
al
report
bovin
pmn
produc
ifnlik
substanc
upon
contact
infect
cell
find
appar
pass
rather
unrecogn
knowledg
similar
find
report
speci
consid
potenti
import
pmn
antivir
immun
warrant
investig
regard
condit
induct
secret
well
physicochem
charcater
antivir
molecul
vitro
system
ifnproduct
liabl
mani
variabl
includ
temperatur
age
cell
passag
level
serumfactor
includ
contamin
endotoxin
contamin
noncytopath
virus
mycoplasma
well
host
cell
induc
influenc
factor
bovin
ifn
product
investig
sever
group
howev
consist
result
appear
result
fulton
pearson
suggest
consider
differ
exist
bovin
continu
cell
line
abil
produc
ifn
respons
virus
addit
passag
level
specif
cell
line
may
also
influenc
result
may
reflect
continu
evolut
cell
cultur
alter
gene
express
possibl
infect
exogen
agent
common
contamin
bovin
cell
serum
bovin
pestiviru
bovin
viral
diarrheaviru
bvdv
diderholm
dinter
found
infect
noncytopath
bvdv
significantli
suppress
ifnrespons
secondari
viral
infect
contrast
rossi
kiesel
found
bvdv
affect
ifn
product
polyriboinosinicpolyribocytidyl
acid
poli
ripoli
rc
thu
may
differ
induc
contamin
may
affect
differ
gene
gene
famili
differ
could
especi
import
viral
protein
glycoprorein
bvdv
affect
host
cell
gene
express
one
isol
bvdv
activ
regard
anoth
could
easili
explain
discrep
report
probabl
exposur
viru
bvdv
could
induc
variou
level
ifn
may
alter
subsequ
ifn
respons
thu
care
taken
insur
cultur
free
exogen
agent
use
analysi
ifn
respons
phenomenon
prime
involv
pretreat
cell
ifn
enhanc
ifnproduct
subsequ
viral
nonvir
stimul
also
occur
bovin
cell
prime
demonstr
occur
ifntyp
gener
found
low
rather
high
dose
impur
ifn
caus
prime
howev
pure
interferon
use
prime
observ
high
dose
high
dose
impur
interferon
also
induc
phenomenon
design
block
latter
phenomenon
observ
bovin
alveolar
mqb
pretreat
pure
rbolfna
subsequ
challeng
observ
may
implic
clinic
use
ifn
time
dose
ifn
applic
may
alter
efficaci
activ
circul
andor
tissu
ifn
detect
cattl
follow
natur
experiment
viru
infect
follow
stimul
variou
chemic
compound
latter
group
compris
poli
ripoli
rc
natur
doubl
strand
chemic
modifi
rna
statolon
unfortun
compound
well
synthet
ifninduc
toxic
therefor
investig
extens
cattl
disadvantag
use
synthet
ifninduc
prevent
veterinari
medicin
recent
discuss
werenn
numer
virus
report
induc
ifn
cattl
includ
newcastl
diseas
viru
vaccinia
viru
bovin
viru
bovin
respiratori
syncyti
viru
bovin
adenoviru
bovin
enteroviru
strain
bvdv
bovin
ibrvipv
bovin
rotavirus
howev
role
ifn
limit
viru
replic
establish
infect
except
sever
group
found
clear
relationship
replic
nasal
passag
ifntit
nasal
secret
contrast
ifn
level
serum
usual
neglig
follow
respiratori
tract
infect
even
though
believ
produc
system
infect
uapublish
data
local
induc
ifn
follow
aerogen
infect
confer
least
partial
protect
secondari
infect
either
unrel
viru
whether
local
produc
ifn
system
effect
alter
outcom
infect
remain
determin
pretreat
calv
cortison
enhanc
ifngener
upon
challeng
probabl
due
corticosteroidinduc
immunosuppress
subsequ
unrestrict
viral
replic
experiment
oral
infect
colostrum
depriv
calv
bovin
rotaviru
result
product
ifn
detect
intestin
content
gut
mucosa
well
serum
presenc
ifn
serum
rather
surpris
sinc
viru
infect
believ
strictli
local
gut
infect
must
indic
adsorpt
ifn
mucos
surfac
effici
process
follow
rotaviru
infect
sever
wave
ifn
product
usual
detect
correl
viru
multipl
gut
invers
relationship
viru
dose
ifn
product
clinic
diseas
seem
exist
high
dose
viru
x
pfu
ifn
produc
earli
within
first
h
pi
clinic
symptom
infect
contrast
lower
dose
viru
x
pfu
ifn
product
delay
viru
induc
transient
diarrhea
howev
role
ifn
limit
infect
former
instanc
must
interpret
caution
sinc
rotaviru
may
dose
level
produc
defect
interf
particl
may
excel
ifn
induc
unabl
induc
diseas
intestin
ifn
produc
respons
enter
viru
infect
partial
sensit
ph
suggest
mixtur
produc
enterocyt
produc
leukocyt
lamina
propriamucosa
suggest
corrobor
antigen
character
gutifn
suggest
serumifn
detect
calv
challeng
oral
rotaviru
primarili
origin
adsorpt
intestin
enterocyteproduc
ifn
weak
viremia
occur
seem
unlik
abl
stimul
pronounc
ifn
respons
howev
also
possibl
blood
leukocyt
avid
ifnproduc
may
produc
ifn
possibl
test
altern
thorough
character
intestin
serumifn
respect
well
specif
role
prevent
viru
replic
either
directli
indirectli
enterocyt
despit
abund
report
possibl
mechan
antivir
activ
ifn
unequivoc
explan
accept
action
singl
mechan
treatment
cell
ifn
inhibit
replic
virus
howev
whatev
mechan
work
particular
cell
type
particular
viru
type
gener
accept
ifn
act
cell
chang
biochemistri
way
viru
replic
either
longer
possibl
least
significantli
reduc
ifn
induc
number
enzym
therebi
prepar
cell
resist
infect
viru
specif
antivir
mechan
may
activ
viru
attach
enter
cell
one
best
character
antivir
mechan
induc
ifn
synthetasernas
pathway
viru
replic
intermedi
dsrna
viral
replic
intermedi
first
activ
least
possibl
mani
synthetas
synthes
seri
adenyl
oligom
also
design
activ
latent
cellular
endornas
rnase
rnase
l
f
cleav
mrna
rrna
constitut
level
enzym
cascad
present
variabl
amount
varieti
cell
tissu
respons
ifn
level
synthetas
may
increas
fold
thu
enzym
use
biochem
marker
sensit
cell
system
anim
ifntreat
recent
appli
bovin
system
dsrna
contain
base
pair
effect
activ
sinc
dsrna
size
normal
found
cell
cytoplasm
strict
sizerequir
ensur
ifninduc
enzym
accident
activ
uninfect
cell
second
well
known
mechan
action
involv
ifninduc
dsrnadepend
protein
kinas
capabl
phosphoryl
alphasubunit
eucaryot
protein
synthesi
initi
factor
subsequ
inhibit
protein
synthesi
whether
pathway
inhibit
protein
synthesi
involv
addit
mechan
viru
inhibit
inhibit
viral
penetr
glycosyl
viral
glycolipid
glycoprotein
viral
assembl
andor
releas
present
known
addit
direct
antivir
mechan
ifn
action
vivo
antivir
effect
ifn
may
mediat
partial
host
thu
activ
cellular
compon
immun
system
natur
killer
nk
cell
cell
kill
virusinfect
cell
antibodi
produc
cell
etc
play
extrem
import
role
limit
viru
infect
viral
pathogenesi
result
numer
effect
ifn
cell
immun
system
difficult
design
vivo
experi
answer
one
specif
question
regard
mechan
ifn
action
verifi
import
endogen
ifn
antivir
resist
gresser
et
al
demonstr
inject
antiifnserum
could
reduc
resist
mice
varieti
virus
recent
also
found
genet
determin
resist
mice
herpesviru
infect
correl
posit
magnitud
earli
local
ifnrespons
thu
ad
substanti
support
hypothesi
ifn
play
import
role
limit
viru
replic
vivo
therebi
alter
caus
effect
viral
infect
regard
vitro
antivir
potenc
bolfn
mani
discrep
appar
appli
sensit
cell
antivir
effect
sensit
variou
virus
given
cell
system
howev
standard
procedur
ifn
assay
follow
variou
group
standard
refer
ifn
employ
investig
direct
comparison
possibl
present
emphas
need
investig
incorpor
intern
standard
ifn
assay
studi
comparison
vitro
sensit
bovin
virus
ifn
perform
rel
insensit
bolfn
regardless
ifntyp
observ
thu
vesicular
stomat
viru
vsv
least
fold
sensit
recent
variabl
sensit
differ
strain
observ
none
nearli
sensit
vsv
find
corrobor
vivo
find
maxim
ifntit
nasal
secret
challeng
calv
occur
simultan
maxim
virustit
exogen
bolfn
appli
intranas
prior
nasal
challeng
reduc
replic
signific
degre
indic
insensit
vivo
direct
antivir
effect
bolfn
virus
reputedli
involv
respiratori
diseas
cattl
show
moder
high
sensit
natur
recombin
bolfn
vitro
howev
vivo
result
cummin
rosenquist
suggest
care
must
exercis
extrapol
vitro
result
might
expect
vivo
probabl
result
direct
indirect
effect
occur
vivo
sever
report
describ
restrict
activ
crude
bolfn
porcin
cell
contrast
purifi
rbolfnetl
antivir
activ
porcin
cell
equal
bovin
cell
boifn
shown
activ
porcin
cell
bovin
cell
howev
context
perhap
reiter
properti
challeng
viru
may
influenc
assay
differ
cell
system
well
cellular
specif
ifn
rinaldo
et
al
report
vivo
bvdvinduc
ifn
higher
activ
ovin
cell
bovin
wherea
rboifna
activ
ovin
caprin
cell
slightli
inferior
seen
bovin
cell
independ
rel
antivir
potenti
boifni
kinet
develop
antivir
state
vitro
sensit
cell
appear
similar
babiuk
unpublish
data
brief
exposur
h
cell
bolfn
unitsml
result
low
reproduc
level
virusyield
inhibit
maximum
inhibit
reach
h
treatment
depend
ifnconcentr
remov
boifn
vitro
cell
system
antivir
state
decay
complet
within
h
babiuk
unpublish
data
promin
among
nonantivir
effect
ifn
exert
cell
immun
system
major
studi
area
conduct
use
vitro
system
advent
pure
clone
ifn
varieti
speci
well
initi
clinic
trial
employ
ifn
vivo
immunomodulatori
effect
intens
investig
experiment
system
clinic
set
use
system
possibl
determin
whether
effect
observ
vitro
isol
system
also
occur
vivo
variou
paramet
immun
system
interact
counteract
howev
valuabl
inform
must
still
retriev
vitro
system
singl
compon
intric
web
immun
defenc
dissect
evalu
separ
well
combin
vitro
studi
help
us
judici
design
vivo
experi
produc
desir
effect
specif
applic
ie
specif
diseas
situat
conduct
final
confirm
conclus
must
eventu
base
vivo
find
advent
recombin
dnatechnolog
impur
prepar
bovin
ifn
avail
vitro
studi
kept
laboratori
concern
veterinari
immunolog
conduct
studi
immunomodulatori
effect
ifn
bovin
speci
murin
human
field
seem
somewhat
curiou
howev
report
immunomodul
properti
bolfn
emerg
found
prevent
treatment
calv
rboifn
benefici
effect
clinic
perform
experiment
ship
fever
without
significantli
reduc
viru
replic
nasal
caviti
studi
initi
elucid
nonantivir
effect
boifn
might
potenti
contribut
observ
organ
system
first
line
cellular
defenc
extran
microorgan
exert
cell
monocytemacrophag
lineag
polymorphonuclear
leukocyt
neutrophil
pmn
eosinophil
pme
effici
wherebi
combat
intrud
may
depend
function
migrat
gener
releas
reactiv
oxygen
speci
eg
hydrogen
peroxid
superoxid
anion
lysosom
enzym
express
surfac
receptor
immunoglobulin
fcr
complement
cr
secret
ifn
prostaglandin
pg
phagocytosi
cellular
cytotox
activ
bovin
cell
modul
vitro
treatment
cell
rbolfna
tabl
function
far
examin
also
subject
vivo
modul
tabl
howev
effect
ifnexposur
appear
depend
dose
exposur
time
health
statu
anim
ie
whether
clinic
healthi
infect
viru
viru
plu
bacteria
influenc
latter
dramat
give
complet
opposit
result
exampl
migrat
ogener
pmn
evalu
present
time
explan
discrep
like
plethora
endogen
factor
releas
viru
infect
somehow
chang
effect
exogen
ifn
anoth
explan
could
consid
benefici
respect
vitro
situat
may
benefici
vivo
exampl
although
product
oxygen
reactiv
speci
may
import
kill
bacteria
may
also
lead
tissu
damag
enhanc
patholog
furthermor
molecul
may
reflect
sever
diseas
therefor
invers
relationship
cellular
activ
diseas
influenc
age
donor
anim
far
detect
regard
sensit
ifnmodul
neither
influenc
anim
genet
makeup
observ
certainti
bovin
speci
although
suspect
play
role
occas
unpublish
data
insight
aspect
may
await
better
character
immun
respons
gene
bovin
speci
genet
factor
influenc
express
ifn
ifn
induc
protein
natur
cellmedi
cytotox
nonspecif
immun
defenc
mechan
exert
still
unclassifi
effector
cell
subset
subset
antigen
antibodi
independ
indic
defencemechan
may
import
antivir
defenc
bovin
speci
cell
exert
natur
cytotox
xenogen
tumor
cell
well
infect
bovin
fibroblast
resid
within
close
relat
mlineag
speci
activ
highli
suscept
vitro
vivo
modul
ifn
respons
increas
upon
exposur
rbolfn
exact
mechan
wherebi
ifn
modul
nc
activ
whether
vitro
vivo
modul
occur
mechan
remain
determin
thu
endogen
vivo
factor
present
vitro
may
modul
effect
exogen
boifn
vivo
enhanc
effect
rboifn
ncactiv
may
involv
direct
indirect
influenc
bone
marrow
ie
develop
recruit
effector
cell
thu
although
rboifnu
vitro
dosedepend
suppress
effect
prolifer
bone
marrow
cell
mqblineag
seem
partial
select
expans
certain
subset
bone
marrow
mob
share
phenotyp
ie
antigen
characterist
nc
cell
peripher
blood
unpublish
data
healthi
calv
treat
intraven
intramuscularli
rboifnoq
mitogen
proliferativerespons
pbl
reduc
h
later
addit
vitro
cultur
partli
complet
prevent
suppress
contrast
later
time
day
treatment
prolif
respons
pbl
con
pha
actual
enhanc
although
vivo
effect
two
ifn
similar
effect
differ
ad
vitro
pbl
cultur
normal
nontreat
anim
thu
concentr
rang
rboifnth
modul
con
pha
respons
vari
enhanc
low
dose
suppress
high
dose
suppress
effect
complet
revert
addit
exogen
could
indic
suppress
effect
exert
either
inhibit
mitogen
stimul
product
cultur
stimul
cell
compet
bind
without
exhibit
prolif
respons
contrast
use
dose
rang
boifnonli
suppress
pha
con
arespons
pbl
rboifnsuppress
overcom
addit
differ
two
ifntyp
may
illustr
differ
physiolog
role
thu
sinc
ifn
actual
produc
mitogenstimul
lymphocyt
cell
cultur
tempt
specul
ifn
serv
initi
enhanc
later
feedback
control
mechan
shut
prolifer
prevent
overreact
immun
respons
recombin
human
ifn
also
found
suppress
prolifer
bovin
pbl
effect
seem
somewhat
caprici
depend
serum
sourc
individu
anim
use
clone
bulk
bovin
cell
demonstr
c
interferon
inhibit
prolifer
respons
unpublish
data
explor
mechan
involv
ifnsuppress
mitogenstimul
lymphocyt
prolifer
effect
rboifn
con
induc
gener
investig
although
result
preliminari
appear
enhanc
gener
follow
vivo
exposur
contrast
consist
effect
could
seen
vitro
exposur
unpublish
data
activ
suppressor
cell
ifn
report
anim
system
possibl
therefor
consid
vitro
treatment
bovin
either
bolfna
endow
suppress
activ
contrari
enhanc
accessori
cell
activ
least
appli
mitogen
respons
contrast
suppressor
cell
lymphocyt
characterist
induc
high
dose
rbolfna
within
hour
exposur
remain
elucid
suppressor
cell
exert
activ
although
inhibitori
effect
rbolfntreat
antibodi
respons
viral
antigen
detect
rbolfneh
profound
effect
vitro
secondari
antibodi
respons
filion
et
al
unpublish
data
fig
mechan
suppress
yet
studi
bovin
system
human
system
shown
due
direct
antiprolif
effect
ifn
rather
via
intermediari
suppressor
cell
mechan
remain
investig
effect
bolfn
might
bovin
antibodyproduc
cell
respons
murin
system
ifnwa
found
enhanc
respons
act
cofactor
drive
matur
rest
b
cell
activ
immunoglobulin
secret
mechan
also
occur
vivo
implic
benefici
effect
combin
immun
vaccin
ifntreat
consider
alreadi
mention
vivo
vitro
exposur
bovin
alveolar
mb
modul
express
immun
receptor
ectoenzym
either
posit
neg
tabl
addit
surfac
antigen
express
affect
notabl
express
mhcii
product
ialik
antigen
rbolfn
particular
activ
regard
activ
ialik
antigen
combin
enhanc
accessori
cell
activ
may
consider
signific
specif
immun
respons
anim
may
actual
one
major
factor
enhanc
immun
respons
follow
vaccin
allow
recoveri
infect
use
ifn
control
bovin
viral
diseas
consid
time
ifn
research
still
infanc
suggest
time
bovin
respiratori
diseas
especi
ship
fever
might
model
choic
evalu
use
ifn
diseas
control
cattl
model
especi
attract
experiment
reproduc
predict
yearli
recurr
field
number
virus
conjectur
involv
last
least
econom
import
cattl
industri
consum
three
differ
strategi
ifntherapi
employ
induct
endogen
ifn
avirul
viral
agent
suitabl
nontox
chemic
compound
local
system
applic
ifn
exogen
sourc
previous
mention
proven
virtual
imposs
optim
system
use
chemicalsynthet
induc
problem
toxic
individu
variat
respons
etc
studi
conduct
date
endogen
ifninduct
challeng
avirul
viru
also
equal
discourag
thu
although
protect
obtain
vivo
ifninduct
supposedli
avirul
strain
vaccin
strain
food
mouth
diseas
viru
virul
bovin
rhinoviru
adenoviru
protect
partial
use
exogen
ifn
seem
strategi
choic
treatment
anim
howev
advent
recombin
dnatechnolog
clone
ifngen
bacteria
subsequ
larg
scale
product
refin
purif
method
product
bolfn
clinic
use
cattl
appear
requir
almost
heroic
effort
certainli
econom
feasibl
present
avail
recombin
e
colideriv
ifn
insur
evalu
applic
control
measur
bovin
viral
diseas
within
forese
futur
recombin
hulfn
test
cattl
experiment
vaccinia
viru
infect
induc
respiratori
diseas
instanc
multipl
inject
ifn
given
although
protect
obtain
individu
variat
sensit
treatment
notabl
moreov
respiratori
diseas
model
toxic
effect
cnsdepress
hyperthermia
result
ifntreat
evid
though
author
tend
neglect
aspect
contrast
effect
seen
hulfn
cattl
appear
toler
extrem
high
dose
rbolfn
detect
toxic
effect
hyperthermia
brief
durat
less
h
dose
unitskg
bodi
weight
rboifn
may
induc
diarrhea
anim
addit
hyperthermia
transient
chang
blood
leukocyt
number
howev
dose
far
exce
dose
necessari
prophylact
effect
rboifni
bovin
respiratori
diseas
unpublish
data
dose
may
reduc
found
differ
boifn
act
synergist
thu
advers
effect
easili
avoid
therapeut
prophylact
situat
pharmacokinet
rboifn
also
differ
maximum
serum
level
ifn
obtain
rboifn
less
seen
rbolfn
regardless
whether
administ
intraven
intramuscularli
whether
reflect
kinet
bind
cell
remain
elucid
bolfni
may
prove
effect
rapidli
bolfn
preliminari
result
suggest
may
inde
case
unpublish
data
base
observ
studi
need
conduct
respect
time
treatment
well
dose
dose
combin
may
especi
import
infect
bovin
respiratori
diseas
differ
effect
would
need
induct
activ
virus
bacteria
involv
diseas
complex
especi
true
employ
vivo
test
viru
appar
neglig
effect
ifn
viral
replic
nasal
caviti
thu
paramet
overal
clinic
perform
ie
sever
durat
symptom
anim
may
prove
better
measur
valu
ifntherapi
least
appli
bovin
respiratori
diseas
singl
treatment
either
rbolfneq
appear
effect
multipl
applic
prevent
ship
fever
symptom
provid
treatment
given
h
prior
virusexposur
unpublish
data
effect
longer
protect
may
requir
field
condit
time
infect
may
alway
known
possibl
variou
deliveri
system
includ
slow
releas
mechan
may
develop
whether
lead
refractori
state
advers
effect
overal
immun
system
need
care
consider
second
econom
import
diseas
activ
immun
feasibl
neonat
diarrhea
instanc
diseas
occur
within
first
wk
life
diseas
caus
wide
varieti
differ
agent
includ
rotaviru
coronaviru
breda
viru
astrovirus
calicivirus
parvovirus
possibl
unidentifi
viral
agent
well
enterotoxigen
e
coli
feasibl
method
control
agent
involv
oral
feed
specif
antibodi
contain
milk
monoclon
antibodi
either
bacteria
specif
virus
sinc
mani
differ
virus
present
identifi
agent
involv
induct
neonat
diarrhea
specif
chemotherapeut
method
appear
potenti
role
inhibit
viru
replic
thu
ifn
broad
spectrum
antivir
activ
appear
ideal
candid
make
cell
refractori
viru
infect
therefor
could
dramat
reduc
econom
loss
due
neonat
diarrhea
present
least
one
report
wherein
intramuscular
treatment
calv
human
ifnet
decreas
symptom
rotaviru
diarrhea
alter
viru
excret
initi
observ
appear
promis
hope
improv
efficaci
could
achiev
better
administr
method
dose
sinc
agent
caus
neonat
calf
diarrhea
gener
restrict
intestin
epithelium
gastrointestin
tract
possibl
administr
ifn
intestin
tract
provid
refractori
antivir
state
would
even
prove
efficaci
system
administr
especi
import
sinc
virus
produc
diarrhea
rapidli
diseas
process
local
howev
type
studi
accept
field
consider
experiment
conduct
determin
whether
ifn
applic
local
intestin
alter
gut
physiolog
whether
replic
crypt
cell
affect
occur
ifn
may
induc
diarrhea
alter
adsorpt
well
influenc
immun
system
anoth
consider
must
taken
account
treatment
calv
ifn
enter
infect
refractori
state
maintain
approxim
wk
time
calv
reach
age
suscept
enter
infect
reduc
order
achiev
continu
refractori
state
suffici
level
ifn
maintain
gut
extend
period
also
remain
determin
whether
ifn
withstand
proteolyt
enzym
within
jejunum
ileum
site
major
virus
replic
proteolyt
enzym
degrad
ifn
novel
approach
system
releas
transport
intestin
surfac
extend
period
requir
thu
evid
mani
question
still
need
address
applic
ifn
neonat
diarrhea
use
guarante
efficaci
secur
major
enter
virus
caus
neonat
diarrhea
calv
easi
cultiv
vitro
therefor
littl
inform
regard
potenti
suscept
ifn
avail
present
evid
bovin
rotaviru
show
littl
suscept
direct
antivir
effect
ifn
howev
appear
vivo
treatment
calv
ifn
efficaci
rotavirus
thu
may
alway
direct
correl
vitro
sensit
virus
ifn
clinic
effect
ifn
alreadi
clearli
demonstr
henc
appear
individu
virus
test
vivo
situat
concret
statement
made
potenti
valu
ifn
treatment
reduct
wide
spectrum
virus
caus
neonat
diarrhea
calv
howev
avail
suffici
quantiti
ifn
anim
model
system
reproduc
neonat
diarrhea
calv
make
studi
feasibl
near
futur
investig
cover
aspect
bovin
ifn
system
well
way
result
obtain
within
last
year
respect
use
rbolfn
control
diseas
appear
encourag
howev
trial
also
extend
includ
import
infect
cattl
addit
viral
infect
without
secondari
bacteri
infect
rboifn
may
prove
use
infect
due
chlamydia
rickettsia
intracellular
parasit
infect
cattl
agent
also
potenti
anim
model
correspond
human
diseas
studi
mechan
wherebi
rboifn
confer
protect
includ
immunomodu
effect
cours
continu
parallel
clinic
evalu
could
contribut
significantli
knowledg
concern
ifn
activ
gener
therapeut
strategi
may
also
consid
evalu
vitro
shown
ifn
virusspecif
antibodi
vab
act
synergist
inhibit
variou
viru
type
effect
probabl
relat
abil
vab
retard
extracellular
spread
viru
reduc
multipl
infect
thu
allow
time
ifn
act
abil
ifn
protect
uninfect
cell
reduc
viru
yield
infect
cell
thu
make
even
low
level
vab
protect
differ
viru
type
may
differ
sensit
vabifn
combin
depend
ifn
type
howev
two
new
tool
monoclon
antibodi
recombin
dna
produc
ifn
investig
variou
permut
possibl
thu
strategi
certainli
lend
exploit
prevent
also
therapi
viru
infect
thu
probabl
far
tap
resourc
ifn
system
potenti
may
still
await
discoveri
excit
use
result
may
ahead
us
control
infecti
diseas
man
anim
envisag
present
